Amryt Pharma

Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

$125.0M raised

Feb 2022

Post-IPO Debt

Biopharma Life Science Medical Pharmaceutical

Top Investors

European Investment Bank Ares Management Highbridge Capital Management Athyrium Capital Management LP Amati Global Investors

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amryt Pharma

How much funding has Amryt Pharma raised?

Amryt Pharma has raised $125.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2022.

Who are Amryt Pharma's investors?

Amryt Pharma's investors include European Investment Bank, Ares Management, Highbridge Capital Management, Athyrium Capital Management LP, Amati Global Investors.

Where is Amryt Pharma headquartered?

Amryt Pharma is headquartered in Dublin, Ireland.

What does Amryt Pharma do?

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

What stage is Amryt Pharma at?

Amryt Pharma is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 22, 2022.

MLA

"Amryt Pharma — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/amryt-pharma. Accessed July 1, 2026.

APA

VCBacked. (2022). Amryt Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/amryt-pharma

Wikipedia (cite web)

{{cite web |title=Amryt Pharma — Funding & Investors |url=https://www.vcbacked.co/company/amryt-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 22, 2022.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.